1 Pablos Mendez A, Raviglione MC, Laszlo A, et al. Global surverillance for anti-tuberculosis drug resistance, 1994-1997[J]. N Engl J Med,1998,338(20):1641~1649
2 全国结核病流行病学抽样调查技术指导组.第四次全国结核病学抽样调査报告[J].中国防痨杂志.2002,25(2):37
3 Espinal MA, Laszol A, Simonsen L, et al. Global trends in resistance to antituberculosis deugs[J]. N Engl J Med.2001,344(17):1294~1303
4 Mukheijee JS, Rich ML, Socci AR, et al. Programmes and principles in treatment of multidnig-resistant tuberculosis[J]. Lancet. 2004,363:474~478
5 韩建平,孙淑丽,李仁忠,等.起始耐药与非耐药肺结核患者近、远期疗效观察[J].中华结核和呼吸杂志.2003,25(2):70~74
6 Reichman LB. Multidrug-resistance in the world: the present situation[J]. Chemotherapy, 1996;42(S12):2
7 陈雪花.氟喹诺酮类药物治疗结核病[J].医药导报,2000,19(1):26~27
8 Tomioka H. Role of new quincdones in the treatment of mycobactaiosis[J]. Kekkaku,2003,78(19):601~604
9 殷凯生,殷民生.实用抗感染药物手册[M].北京:人民卫生出版社,2001:294~302
10 陆宇,朱莉贞,段连山.氟喹诺酮类药物的抗结核作用[J].中国结核和呼吸杂志,1999,22(11):694~696
11 仲兆金.喹诺酮类药物在肺结核治疗中的作用[J].国外医药抗生素分册,2002,23(3):137~140
12 Rastogi N, Goh KS,Btyskier A, et al. In vitro activities of levoflaxacin used alone and seccnd line anti-tuberculosis drugs against Mycobacterium tubemdosis[J]. Antimicrob Agent Chemother,1996,40(5):1610~1616
13 Kocagoz Y, Hackbarth CJ, et al. Gyrase mutations in laboratory-se-lected, fluoroquinolone resistance mutants of mycobacterium tuberculosis H34Rv[J]. Antimicrobial Agents Chemother,1996,40(8):1768~1774
14 Onodera Y, Tanaka M, Sato K. Inhibitory acliveity of quinolones aginst DNA gyrace of Mycobacterium tuberculosis[J]. Antimicrobial Agents Chemother,2001,47(1):447~450
15 Cheng AF, Yew WW, Chen EW, et al. Multiplex PCR amplimer quinolone-resistant Mycobacterium tuberculosis chinical isolates[J].Antimicrob Agenta Chemother,2004,48(2):596~601
16 李拥军,王玉华.抗痨并氧氟沙星治疗难治性肺结核32例[J].第四军医大学学报,2003,24(18):1690
17 唐神结,潘金凤,黄彩柳,等.环丙氟哌酸治疗多耐药肺结核近远期疗效的观察[J].中国防痨杂志,1999;21(2):87
18 Valerio G, Bracciale P, Manisco V, et al. Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results[J]. Chemother.2003,15(1):66~70
19 汤茂功,曹尔渊.氧氟沙星与环丙沙星复治菌阳肺结核疗效比较[J].苏州医学院学报,1999;19(5):592
20 黄朝生,吴春城.司帕沙星治疗耐多药肺结核疗效观察[J].中国抗生素杂志,2000;25(4):302~3M
21 WHO/IUATLD Global Working Group on Antituberculosis Drug Resistance Surveillance. Guidelines for surveillance of drug resistance in tuberculosis[M]. Geneva: WHO, 1996
22 中国防痨协会.耐多药结核病化学治疗意见(试行)[J].中国防痨杂志,2003,25(1):4~9
23 马玙.如何认识喹诺酮类药物的抗结核作用?临床如何应用?[J].中华结核和呼吸杂志,2002,25(12):715~716
|